Most importantly, CSF1-R and c-Kit receptor inhibitor masitinib prevented SC reactivity in degenerating nerves and ameliorated sciatic nerve pathology in ALS rats. This evidence concerns the gene CSF1R and amyotrophic lateral sclerosis.